Anti-CD3 × Anti-HER2 Bispecific Antibody Effectively Redirects Armed T Cells to Inhibit Tumor Development and Growth in Hormone-Refractory Prostate Cancer–Bearing Severe Combined Immunodeficient Beige Mice

2004 ◽  
Vol 3 (2) ◽  
pp. 112-121 ◽  
Author(s):  
Pamela A. Davol ◽  
Janelle A. Smith ◽  
Nicola Kouttab ◽  
Gerald J. Elfenbein ◽  
Lawrence G. Lum
Keyword(s):  
Prostate Cancer ◽  
T Cells ◽  
Bispecific Antibody ◽  
Tumor Development ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

A phase I/II trial of CD3/CD28 activated T cells (Xcellerated T Cells) in patients with hormone refractory prostate cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2549-2549 ◽  
Author(s):  
M. L. Glode ◽  
A. Pantuck ◽  
C. S. Higano ◽  
J. Meyer ◽  
L. Hami ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
T Cells ◽  
Phase I ◽  
Hormone Refractory Prostate Cancer ◽  
Activated T Cells ◽  
Hormone Refractory

scholarly journals Targeting Human γδ T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer

2007 ◽  
Vol 67 (15) ◽  
pp. 7450-7457 ◽  
Author(s):  
Francesco Dieli ◽  
David Vermijlen ◽  
Fabio Fulfaro ◽  
Nadia Caccamo ◽  
Serena Meraviglia ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
T Cells ◽  
Interleukin 2 ◽  
Γδ T Cells ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

A phase I/II trial of CD3/CD28 activated T cells (Xcellerated T Cells) in patients with hormone refractory prostate cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2549-2549
Author(s):  
M. L. Glode ◽  
A. Pantuck ◽  
C. S. Higano ◽  
J. Meyer ◽  
L. Hami ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
T Cells ◽  
Phase I ◽  
Hormone Refractory Prostate Cancer ◽  
Activated T Cells ◽  
Hormone Refractory

604: A Phase I Trial of Vaccination of Personalized Peptides for HLA-A2/A24 Positive Patients with Hormone-Refractory Prostate Cancer

2007 ◽  
Vol 177 (4S) ◽  
pp. 202-202
Author(s):  
Hirotsugu Uemura ◽  
Motoyoshi Tanaka ◽  
Shigeya Uejima ◽  
Takafumi Minami ◽  
Kiyohide Fujimoto ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

829: PSA-Flare up in Docetaxel Therapy of Hormone-Refractory Prostate cancer (HRPCA): Incidence and Clinical Impact?

2005 ◽  
Vol 173 (4S) ◽  
pp. 225-225
Author(s):  
Peter Olbert ◽  
Andres J. Schrader ◽  
Axel Hegele ◽  
Zoltan Varga ◽  
Axel Heidenreich ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Impact ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory
Sign in / Sign up

Export Citation Format

Share Document